UBS O'Connor’s Wave Life Sciences WVE Stock Holding History

UBS O'Connor’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-39,767	Closed	-$492K	–	474
2024 Q4	$492K	Buy	+39,767	New	+$531K	0.01%	286

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

UBS O'Connor's WVE Position: Q1 2025 in Review

UBS O'Connor sold out of Wave Life Sciences (WVE) in Q1 2025, closing a stake of 39,767 shares — an estimated $492K sold.

UBS O'Connor first reported a position in WVE in Q4 2024 and held it in 1 quarter. The position peaked at $492K in Q4 2024. 196 funds tracked by Wall St. Rank hold WVE as of Q1 2025.

UBS O'Connor reported no remaining Wave Life Sciences position as of Q1 2025 after selling out during the quarter.
UBS O'Connor sold 39,767 Wave Life Sciences shares in Q1 2025, an estimated $492K.
UBS O'Connor first reported a position in Wave Life Sciences in Q4 2024 and held it in 1 quarter.
UBS O'Connor's Wave Life Sciences position peaked at $492K in Q4 2024.
196 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.